Captrust Financial Advisors Renovo Rx, Inc. Transaction History
Captrust Financial Advisors
- $43.1 Billion
- Q2 2025
A detailed history of Captrust Financial Advisors transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 12,307 shares of RNXT stock, worth $12,553. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,307Holding current value
$12,553% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RNXT
# of Institutions
29Shares Held
8.91MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD2.62MShares$2.67 Million0.55% of portfolio
-
Awm Investment Company, Inc. New York, NY1.87MShares$1.91 Million0.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$1.7 Million0.0% of portfolio
-
Bank Of The West975KShares$994,5000.27% of portfolio
-
Bleichroeder LP New York, NY500KShares$510,0000.21% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $9.25M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...